Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea flag South Korea · Delayed Price · Currency is KRW
53,600
+2,800 (5.51%)
Nov 17, 2026, 3:30 PM KST

Hanall Biopharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,725,9992,221,6191,959,9522,245,705902,2901,077,892
Market Cap Growth
22.84%13.35%-12.72%148.89%-16.29%-43.84%
Enterprise Value
2,740,7982,211,0371,934,1972,185,410836,710991,822
Last Close Price
50800.0043750.0038650.0044300.0017800.0021050.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---640.063588.03121.16
Forward PE
325.80293.05117.15261.09112.3065.12
PS Ratio
15.8814.3214.1116.658.2010.61
PB Ratio
15.9913.7411.6412.065.366.59
P/TBV Ratio
24.4814.1311.9612.185.436.68
P/FCF Ratio
--253.9382.4740.22-
P/OCF Ratio
--209.4075.7635.711283.40
PEG Ratio
-2.992.530.9819.0919.09

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
15.9714.2513.9216.207.619.76
EV/EBITDA Ratio
-1134.12577.20437.93183.5577.34
EV/EBIT Ratio
--8392.221253.51555.6698.21
EV/FCF Ratio
--250.6080.2637.30-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.280.200.010.010.010.01
Debt / EBITDA Ratio
6.1816.370.430.260.290.10
Debt / FCF Ratio
--0.190.050.06-
Net Debt / Equity Ratio
0.090.04-0.14-0.30-0.31-0.48
Net Debt / EBITDA Ratio
2.033.68-6.94-11.06-11.54-6.18
Net Debt / FCF Ratio
-1.37-2.18-3.01-2.03-2.3521.04
Asset Turnover
0.750.710.610.600.530.49
Inventory Turnover
1.951.961.882.082.112.05
Quick Ratio
0.820.991.292.102.974.35
Current Ratio
1.491.912.463.023.925.37
Return on Equity (ROE)
-15.68%-3.37%-1.02%1.98%0.15%5.16%
Return on Assets (ROA)
1.14%-0.46%0.06%0.48%0.46%3.02%
Return on Invested Capital (ROIC)
2.26%-1.03%0.17%1.41%0.20%11.52%
Return on Capital Employed (ROCE)
2.20%-0.90%0.10%0.90%0.80%5.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.92%-0.25%-0.09%0.16%0.03%0.83%
FCF Yield
-0.42%-0.15%0.39%1.21%2.49%-0.35%
Buyback Yield / Dilution
-0.07%-0.13%-0.04%0.24%0.76%-0.05%